775 related articles for article (PubMed ID: 19080664)
21. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.
Ajani JA; Mansfield PF; Crane CH; Wu TT; Lunagomez S; Lynch PM; Janjan N; Feig B; Faust J; Yao JC; Nivers R; Morris J; Pisters PW
J Clin Oncol; 2005 Feb; 23(6):1237-44. PubMed ID: 15718321
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
[TBL] [Abstract][Full Text] [Related]
23. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
Wang LS; Chi KH; Hu MH; Fahn HJ; Huang MH
J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
[TBL] [Abstract][Full Text] [Related]
24. [A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis].
YANG H; FU JH; LIU MZ; FANG WT; WANG JM; CHEN YP; CHEN ZJ; XIANG JQ; YANG HJ; MAO WM; ZHENG X; ZHU CC; KONG M; HAN YT; LI T
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(15):1028-32. PubMed ID: 22781642
[TBL] [Abstract][Full Text] [Related]
25. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
27. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.
Adham M; Baulieux J; Mornex F; de La Roche de Bransat E; Ducerf C; Souquet JC; Gerard JP
Cancer; 2000 Sep; 89(5):946-54. PubMed ID: 10964323
[TBL] [Abstract][Full Text] [Related]
28. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
29. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M
World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
[TBL] [Abstract][Full Text] [Related]
30. [A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma].
An FS; Huang JQ; Xie YT; Chen SH; Rong TH
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):376-9. PubMed ID: 12921571
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trial.
Dipetrillo T; Suntharalingam M; Ng T; Fontaine J; Horiba N; Oldenburg N; Perez K; Birnbaum A; Battafarano R; Burrows W; Safran H
Am J Clin Oncol; 2012 Feb; 35(1):64-7. PubMed ID: 21297434
[TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
33. Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
Barone C; Grillo R; Dongiovanni D; Birocco N; Rampino M; Redda MG; Garibaldi E; Munoz F; Pecorari G; Cavalot A; Garzinodemo P; Buffoni L; Ciuffreda L; Ricardi U; Cortesina G; Giordano C; Fasolis M; Berrone S; Bertetto O; Schena M
Anticancer Res; 2008; 28(2B):1285-91. PubMed ID: 18505067
[TBL] [Abstract][Full Text] [Related]
34. [Neo-adjuvant chemoradiotherapy followed by surgery in treatment of advanced esophageal carcinoma].
Yang H; Fu JH; Hu Y; Lin P; Liu MZ; Li Q; Fang ZC; Hu YH
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(45):3182-5. PubMed ID: 19171088
[TBL] [Abstract][Full Text] [Related]
35. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.
Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T
Gynecol Oncol; 2006 Oct; 103(1):155-9. PubMed ID: 16545437
[TBL] [Abstract][Full Text] [Related]
36. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction.
Posner MC; Gooding WE; Landreneau RJ; Rosenstein MM; Clarke MR; Peterson MS; Lembersky BC
Cancer J Sci Am; 1998; 4(4):237-46. PubMed ID: 9689982
[TBL] [Abstract][Full Text] [Related]
37. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
38. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
39. Chemoradiation for esophageal cancer: institutional experience with three different regimens.
Courrech Staal EF; Aleman BM; van Velthuysen ML; Cats A; Boot H; Jansen EP; van Coevorden F; van Sandick JW
Am J Clin Oncol; 2011 Aug; 34(4):343-9. PubMed ID: 20562589
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
